Serveur d'exploration sur Heinrich Schütz

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Molecular mechanisms of insulin resistance

Identifieur interne : 000759 ( Main/Exploration ); précédent : 000758; suivant : 000760

Molecular mechanisms of insulin resistance

Auteurs : S. Schinner ; W. A. Scherbaum ; S. R. Bornstein [Allemagne] ; A. Barthel

Source :

RBID : ISTEX:A5EE02E9E97090FE436C5807A19468EE48827456

Mots-clés :

Abstract

Currently, we observe an epidemic expansion of diabetes mellitus. In subjects with Type 2 diabetes the resistance of fat, muscle and liver to insulin is the central pathophysiological event in the development of this disease. Genetic and environmental factors play a major role in this process, although the precise pathogenesis of insulin resistance and Type 2 diabetes is still largely unknown. However, recent studies have contributed to a deeper understanding of the molecular mechanisms underlying this process. In this review we therefore summarize the current developments in understanding the pathophysiological process of insulin resistance and Type 2 diabetes. Among the many molecules involved in the intracellular processing of the signal provided by insulin, insulin receptor substrate (IRS)‐2, the protein kinase B (PKB)‐β isoform and the forkhead transcription factor Foxo1a (FKHR) are of particular interest in this context as recent data have provided strong evidence that dysfunction of these proteins results in insulin resistance in‐vivo. Furthermore, we have now increasing evidence that the adipose tissue not only produces free fatty acids that contribute to insulin resistance, but also acts as a relevant endocrine organ producing mediators (adipokines) that can modulate insulin signalling. The identification of the molecular pathophysiological mechanisms of insulin resistance and Type 2 diabetes is essential for the development of novel and more effective therapies to better treat our patients with insulin resistance and Type 2 diabetes.


Url:
DOI: 10.1111/j.1464-5491.2005.01566.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Molecular mechanisms of insulin resistance</title>
<author>
<name sortKey="Schinner, S" sort="Schinner, S" uniqKey="Schinner S" first="S." last="Schinner">S. Schinner</name>
</author>
<author>
<name sortKey="Scherbaum, W A" sort="Scherbaum, W A" uniqKey="Scherbaum W" first="W. A." last="Scherbaum">W. A. Scherbaum</name>
</author>
<author>
<name sortKey="Bornstein, S R" sort="Bornstein, S R" uniqKey="Bornstein S" first="S. R." last="Bornstein">S. R. Bornstein</name>
</author>
<author>
<name sortKey="Barthel, A" sort="Barthel, A" uniqKey="Barthel A" first="A." last="Barthel">A. Barthel</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A5EE02E9E97090FE436C5807A19468EE48827456</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1111/j.1464-5491.2005.01566.x</idno>
<idno type="url">https://api.istex.fr/document/A5EE02E9E97090FE436C5807A19468EE48827456/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000C40</idno>
<idno type="wicri:Area/Main/Curation">000C35</idno>
<idno type="wicri:Area/Main/Exploration">000759</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Molecular mechanisms of insulin resistance</title>
<author>
<name sortKey="Schinner, S" sort="Schinner, S" uniqKey="Schinner S" first="S." last="Schinner">S. Schinner</name>
<affiliation>
<wicri:noCountry code="subField">Düsseldorf</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Scherbaum, W A" sort="Scherbaum, W A" uniqKey="Scherbaum W" first="W. A." last="Scherbaum">W. A. Scherbaum</name>
<affiliation>
<wicri:noCountry code="subField">Düsseldorf</wicri:noCountry>
</affiliation>
<affiliation>
<wicri:noCountry code="subField">Düsseldorf and</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bornstein, S R" sort="Bornstein, S R" uniqKey="Bornstein S" first="S. R." last="Bornstein">S. R. Bornstein</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medizinische Klinik III, Universitäts Klinikum Carl Gustav Carus, Dresden</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Saxe (Land)</region>
<region type="district" nuts="2">District de Dresde</region>
<settlement type="city">Dresde</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Barthel, A" sort="Barthel, A" uniqKey="Barthel A" first="A." last="Barthel">A. Barthel</name>
<affiliation>
<wicri:noCountry code="subField">Düsseldorf</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Diabetic Medicine</title>
<idno type="ISSN">0742-3071</idno>
<idno type="eISSN">1464-5491</idno>
<imprint>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2005-06">2005-06</date>
<biblScope unit="volume">22</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="674">674</biblScope>
<biblScope unit="page" to="682">682</biblScope>
</imprint>
<idno type="ISSN">0742-3071</idno>
</series>
<idno type="istex">A5EE02E9E97090FE436C5807A19468EE48827456</idno>
<idno type="DOI">10.1111/j.1464-5491.2005.01566.x</idno>
<idno type="ArticleID">DME1566</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0742-3071</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>PI 3‐kinase</term>
<term>adipokines</term>
<term>diabetes mellitus Type 2</term>
<term>insulin resistance</term>
<term>protein kinase B</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Currently, we observe an epidemic expansion of diabetes mellitus. In subjects with Type 2 diabetes the resistance of fat, muscle and liver to insulin is the central pathophysiological event in the development of this disease. Genetic and environmental factors play a major role in this process, although the precise pathogenesis of insulin resistance and Type 2 diabetes is still largely unknown. However, recent studies have contributed to a deeper understanding of the molecular mechanisms underlying this process. In this review we therefore summarize the current developments in understanding the pathophysiological process of insulin resistance and Type 2 diabetes. Among the many molecules involved in the intracellular processing of the signal provided by insulin, insulin receptor substrate (IRS)‐2, the protein kinase B (PKB)‐β isoform and the forkhead transcription factor Foxo1a (FKHR) are of particular interest in this context as recent data have provided strong evidence that dysfunction of these proteins results in insulin resistance in‐vivo. Furthermore, we have now increasing evidence that the adipose tissue not only produces free fatty acids that contribute to insulin resistance, but also acts as a relevant endocrine organ producing mediators (adipokines) that can modulate insulin signalling. The identification of the molecular pathophysiological mechanisms of insulin resistance and Type 2 diabetes is essential for the development of novel and more effective therapies to better treat our patients with insulin resistance and Type 2 diabetes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>District de Dresde</li>
<li>Saxe (Land)</li>
</region>
<settlement>
<li>Dresde</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Barthel, A" sort="Barthel, A" uniqKey="Barthel A" first="A." last="Barthel">A. Barthel</name>
<name sortKey="Scherbaum, W A" sort="Scherbaum, W A" uniqKey="Scherbaum W" first="W. A." last="Scherbaum">W. A. Scherbaum</name>
<name sortKey="Schinner, S" sort="Schinner, S" uniqKey="Schinner S" first="S." last="Schinner">S. Schinner</name>
</noCountry>
<country name="Allemagne">
<region name="Saxe (Land)">
<name sortKey="Bornstein, S R" sort="Bornstein, S R" uniqKey="Bornstein S" first="S. R." last="Bornstein">S. R. Bornstein</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/corpus/SchutzV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000759 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    SchutzV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A5EE02E9E97090FE436C5807A19468EE48827456
   |texte=   Molecular mechanisms of insulin resistance
}}

Wicri

This area was generated with Dilib version V0.6.20.
Data generation: Sun Apr 10 01:23:10 2016. Site generation: Fri Aug 18 21:45:27 2017